APO Research
Talk to an analyst

APO RESEARCH · REPORT

Microneedle-mediated Drug Delivery Patch

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Microneedle-mediated Drug Delivery Patch Market Outlook and Growth Opportunities 2026

4 July 2026191 pages

Choose your research edition.

Industry ResearchMicroneedle-mediated Drug Delivery Patch Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Microneedle-mediated Drug Delivery Patch Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Microneedle-mediated Drug Delivery Patch Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Microneedle-mediated Drug Delivery Patch Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Microneedle-mediated Drug Delivery Patch Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Microneedle-mediated Drug Delivery Patch market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Microneedle-mediated Drug Delivery Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Microneedle-mediated Drug Delivery Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Microneedle-mediated Drug Delivery Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Microneedle-mediated Drug Delivery Patch market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Microneedle-mediated Drug Delivery Patch market include KINDEVA, Zosano Pharma, Vaxxas, Valeritas, TheraJect, Inc, Nitto, Nanopass Technologies, Microdermics and Lohmann Therapie-Systeme AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Microneedle-mediated Drug Delivery Patch market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Microneedle-mediated Drug Delivery Patch and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Microneedle-mediated Drug Delivery Patch sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Microneedle-mediated Drug Delivery Patch market size, projected growth trends, production technologies, key applications, and end-use industries.

Microneedle-mediated Drug Delivery Patch Segment by Company

KINDEVA

Zosano Pharma

Vaxxas

Valeritas

TheraJect, Inc

Nitto

Nanopass Technologies

Microdermics

Lohmann Therapie-Systeme AG

Corium

Becton-Dickinson(BD)Technologies

Microneedle-mediated Drug Delivery Patch Segment by Type

Solid Microneedle Technology

Hollow Microneedle Technology

Dissolving Microneedles Technology

Microneedle-mediated Drug Delivery Patch Segment by Application

Hospital

Retail Pharmacy

Others

Microneedle-mediated Drug Delivery Patch Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Microneedle-mediated Drug Delivery Patch status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Microneedle-mediated Drug Delivery Patch market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Microneedle-mediated Drug Delivery Patch significant trends, drivers, influence factors in global and regions.

6. To analyze Microneedle-mediated Drug Delivery Patch competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microneedle-mediated Drug Delivery Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Microneedle-mediated Drug Delivery Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microneedle-mediated Drug Delivery Patch.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Microneedle-mediated Drug Delivery Patch market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Microneedle-mediated Drug Delivery Patch industry.

Chapter 3: Detailed analysis of Microneedle-mediated Drug Delivery Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Microneedle-mediated Drug Delivery Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Microneedle-mediated Drug Delivery Patch in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Microneedle-mediated Drug Delivery Patch Industry Trends Table 2. Microneedle-mediated Drug Delivery Patch Industry Drivers Table 3. Microneedle-mediated Drug Delivery Patch Industry Opportunities and Challenges Table 4. Microneedle-mediated Drug Delivery Patch Industry Restraints Table 5. Global Microneedle-mediated Drug Delivery Patch Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Microneedle-mediated Drug Delivery Patch Revenue Share by Company (2021-2026) Table 7. Global Microneedle-mediated Drug Delivery Patch Sales Volume by Company (k units) & (2021-2026) Table 8. Global Microneedle-mediated Drug Delivery Patch Sales Volume Share by Company (2021-2026) Table 9. Global Microneedle-mediated Drug Delivery Patch Average Price (USD/unit) of Company (2021-2026) Table 10. Global Microneedle-mediated Drug Delivery Patch Company Ranking, (2024-2026) & (USD Million) Table 11. Global Microneedle-mediated Drug Delivery Patch Key Company Manufacturing Base & Headquarters Table 12. Global Microneedle-mediated Drug Delivery Patch Company, Product Type & Application Table 13. Global Microneedle-mediated Drug Delivery Patch Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Microneedle-mediated Drug Delivery Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Solid Microneedle Technology Table 18. Significant Companies of Hollow Microneedle Technology Table 19. Significant Companies of Dissolving Microneedles Technology Table 20. Global Microneedle-mediated Drug Delivery Patch Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Microneedle-mediated Drug Delivery Patch Sales Volume by Type (2021-2026) & (k units) Table 22. Global Microneedle-mediated Drug Delivery Patch Sales Volume by Type (2027-2032) & (k units) Table 23. Global Microneedle-mediated Drug Delivery Patch Sales Volume Share by Type (2021-2026) Table 24. Global Microneedle-mediated Drug Delivery Patch Sales Volume Share by Type (2027-2032) Table 25. Global Microneedle-mediated Drug Delivery Patch Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Microneedle-mediated Drug Delivery Patch Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Microneedle-mediated Drug Delivery Patch Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Microneedle-mediated Drug Delivery Patch Sales Value Share by Type (2021-2026) Table 29. Global Microneedle-mediated Drug Delivery Patch Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Retail Pharmacy Table 32. Significant Companies of Others Table 33. Global Microneedle-mediated Drug Delivery Patch Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Microneedle-mediated Drug Delivery Patch Sales Volume by Application (2021-2026) & (k units) Table 35. Global Microneedle-mediated Drug Delivery Patch Sales Volume by Application (2027-2032) & (k units) Table 36. Global Microneedle-mediated Drug Delivery Patch Sales Volume Share by Application (2021-2026) Table 37. Global Microneedle-mediated Drug Delivery Patch Sales Volume Share by Application (2027-2032) Table 38. Global Microneedle-mediated Drug Delivery Patch Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Microneedle-mediated Drug Delivery Patch Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Microneedle-mediated Drug Delivery Patch Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Microneedle-mediated Drug Delivery Patch Sales Value Share by Application (2021-2026) Table 42. Global Microneedle-mediated Drug Delivery Patch Sales Value Share by Application (2027-2032) Table 43. Global Microneedle-mediated Drug Delivery Patch Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Microneedle-mediated Drug Delivery Patch Sales by Region (2021-2026) & (k units) Table 45. Global Microneedle-mediated Drug Delivery Patch Sales Market Share by Region (2021-2026) Table 46. Global Microneedle-mediated Drug Delivery Patch Sales by Region (2027-2032) & (k units) Table 47. Global Microneedle-mediated Drug Delivery Patch Sales Market Share by Region (2027-2032) Table 48. Global Microneedle-mediated Drug Delivery Patch Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Microneedle-mediated Drug Delivery Patch Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Microneedle-mediated Drug Delivery Patch Sales Value Share by Region (2021-2026) Table 51. Global Microneedle-mediated Drug Delivery Patch Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Microneedle-mediated Drug Delivery Patch Sales Value Share by Region (2027-2032) Table 53. Global Microneedle-mediated Drug Delivery Patch Market Average Price (USD/unit) by Region (2021-2026) Table 54. Global Microneedle-mediated Drug Delivery Patch Market Average Price (USD/unit) by Region (2027-2032) Table 55. Global Microneedle-mediated Drug Delivery Patch Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Microneedle-mediated Drug Delivery Patch Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Microneedle-mediated Drug Delivery Patch Sales by Country (2021-2026) & (k units) Table 58. Global Microneedle-mediated Drug Delivery Patch Sales Market Share by Country (2021-2026) Table 59. Global Microneedle-mediated Drug Delivery Patch Sales by Country (2027-2032) & (k units) Table 60. Global Microneedle-mediated Drug Delivery Patch Sales Market Share by Country (2027-2032) Table 61. Global Microneedle-mediated Drug Delivery Patch Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Microneedle-mediated Drug Delivery Patch Sales Value Market Share by Country (2021-2026) Table 63. Global Microneedle-mediated Drug Delivery Patch Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Microneedle-mediated Drug Delivery Patch Sales Value Market Share by Country (2027-2032) Table 65. KINDEVA Company Information Table 66. KINDEVA Business Overview Table 67. KINDEVA Microneedle-mediated Drug Delivery Patch Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 68. KINDEVA Microneedle-mediated Drug Delivery Patch Product Portfolio Table 69. KINDEVA Recent Development Table 70. Zosano Pharma Company Information Table 71. Zosano Pharma Business Overview Table 72. Zosano Pharma Microneedle-mediated Drug Delivery Patch Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 73. Zosano Pharma Microneedle-mediated Drug Delivery Patch Product Portfolio Table 74. Zosano Pharma Recent Development Table 75. Vaxxas Company Information Table 76. Vaxxas Business Overview Table 77. Vaxxas Microneedle-mediated Drug Delivery Patch Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 78. Vaxxas Microneedle-mediated Drug Delivery Patch Product Portfolio Table 79. Vaxxas Recent Development Table 80. Valeritas Company Information Table 81. Valeritas Business Overview Table 82. Valeritas Microneedle-mediated Drug Delivery Patch Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 83. Valeritas Microneedle-mediated Drug Delivery Patch Product Portfolio Table 84. Valeritas Recent Development Table 85. TheraJect, Inc Company Information Table 86. TheraJect, Inc Business Overview Table 87. TheraJect, Inc Microneedle-mediated Drug Delivery Patch Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. TheraJect, Inc Microneedle-mediated Drug Delivery Patch Product Portfolio Table 89. TheraJect, Inc Recent Development Table 90. Nitto Company Information Table 91. Nitto Business Overview Table 92. Nitto Microneedle-mediated Drug Delivery Patch Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Nitto Microneedle-mediated Drug Delivery Patch Product Portfolio Table 94. Nitto Recent Development Table 95. Nanopass Technologies Company Information Table 96. Nanopass Technologies Business Overview Table 97. Nanopass Technologies Microneedle-mediated Drug Delivery Patch Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Nanopass Technologies Microneedle-mediated Drug Delivery Patch Product Portfolio Table 99. Nanopass Technologies Recent Development Table 100. Microdermics Company Information Table 101. Microdermics Business Overview Table 102. Microdermics Microneedle-mediated Drug Delivery Patch Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Microdermics Microneedle-mediated Drug Delivery Patch Product Portfolio Table 104. Microdermics Recent Development Table 105. Lohmann Therapie-Systeme AG Company Information Table 106. Lohmann Therapie-Systeme AG Business Overview Table 107. Lohmann Therapie-Systeme AG Microneedle-mediated Drug Delivery Patch Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Lohmann Therapie-Systeme AG Microneedle-mediated Drug Delivery Patch Product Portfolio Table 109. Lohmann Therapie-Systeme AG Recent Development Table 110. Corium Company Information Table 111. Corium Business Overview Table 112. Corium Microneedle-mediated Drug Delivery Patch Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Corium Microneedle-mediated Drug Delivery Patch Product Portfolio Table 114. Corium Recent Development Table 115. Becton-Dickinson(BD)Technologies Company Information Table 116. Becton-Dickinson(BD)Technologies Business Overview Table 117. Becton-Dickinson(BD)Technologies Microneedle-mediated Drug Delivery Patch Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Becton-Dickinson(BD)Technologies Microneedle-mediated Drug Delivery Patch Product Portfolio Table 119. Becton-Dickinson(BD)Technologies Recent Development Table 120. Key Raw Materials Table 121. Raw Materials Key Suppliers Table 122. Microneedle-mediated Drug Delivery Patch Distributors List Table 123. Microneedle-mediated Drug Delivery Patch Customers List Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. Microneedle-mediated Drug Delivery Patch Product Image Figure 2. Global Microneedle-mediated Drug Delivery Patch Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Microneedle-mediated Drug Delivery Patch Sales Value (2021-2032) & (US$ Million) Figure 4. Global Microneedle-mediated Drug Delivery Patch Sales (2021-2032) & (k units) Figure 5. Global Microneedle-mediated Drug Delivery Patch Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Microneedle-mediated Drug Delivery Patch Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Solid Microneedle Technology Image Figure 10. Hollow Microneedle Technology Image Figure 11. Dissolving Microneedles Technology Image Figure 12. Global Microneedle-mediated Drug Delivery Patch Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Microneedle-mediated Drug Delivery Patch Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Microneedle-mediated Drug Delivery Patch Sales Volume Share by Type (2021-2032) Figure 15. Global Microneedle-mediated Drug Delivery Patch Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Microneedle-mediated Drug Delivery Patch Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Microneedle-mediated Drug Delivery Patch Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Retail Pharmacy Image Figure 20. Others Image Figure 21. Global Microneedle-mediated Drug Delivery Patch Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Microneedle-mediated Drug Delivery Patch Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Microneedle-mediated Drug Delivery Patch Sales Volume Share by Application (2021-2032) Figure 24. Global Microneedle-mediated Drug Delivery Patch Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Microneedle-mediated Drug Delivery Patch Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Microneedle-mediated Drug Delivery Patch Sales Value Share by Application (2021-2032) Figure 27. Global Microneedle-mediated Drug Delivery Patch Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Microneedle-mediated Drug Delivery Patch Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Microneedle-mediated Drug Delivery Patch Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Microneedle-mediated Drug Delivery Patch Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Microneedle-mediated Drug Delivery Patch Sales Value (2021-2032) & (US$ Million) Figure 32. North America Microneedle-mediated Drug Delivery Patch Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Microneedle-mediated Drug Delivery Patch Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Microneedle-mediated Drug Delivery Patch Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Microneedle-mediated Drug Delivery Patch Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Microneedle-mediated Drug Delivery Patch Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Microneedle-mediated Drug Delivery Patch Sales Value (2021-2032) & (US$ Million) Figure 38. South America Microneedle-mediated Drug Delivery Patch Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Microneedle-mediated Drug Delivery Patch Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Microneedle-mediated Drug Delivery Patch Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Microneedle-mediated Drug Delivery Patch Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Microneedle-mediated Drug Delivery Patch Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Solid Microneedle Technology
  • Hollow Microneedle Technology
  • Dissolving Microneedles Technology
Applications
  • Hospital
  • Retail Pharmacy
  • Others
Companies covered
  • KINDEVA
  • Zosano Pharma
  • Vaxxas
  • Valeritas
  • TheraJect, Inc
  • Nitto
  • Nanopass Technologies
  • Microdermics
  • Lohmann Therapie-Systeme AG
  • Corium
  • Becton-Dickinson(BD)Technologies

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Microneedle-mediated Drug Delivery Patch Sales Value (2021-2032)
  4. 1.2.2 Global Microneedle-mediated Drug Delivery Patch Sales Volume (2021-2032)
  5. 1.2.3 Global Microneedle-mediated Drug Delivery Patch Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Microneedle-mediated Drug Delivery Patch Market Dynamics
  1. 2.1 Microneedle-mediated Drug Delivery Patch Industry Trends
  2. 2.2 Microneedle-mediated Drug Delivery Patch Industry Drivers
  3. 2.3 Microneedle-mediated Drug Delivery Patch Industry Opportunities and Challenges
  4. 2.4 Microneedle-mediated Drug Delivery Patch Industry Restraints
3 Microneedle-mediated Drug Delivery Patch Market by Company
  1. 3.1 Global Microneedle-mediated Drug Delivery Patch Company Revenue Ranking in 2025
  2. 3.2 Global Microneedle-mediated Drug Delivery Patch Revenue by Company (2021-2026)
  3. 3.3 Global Microneedle-mediated Drug Delivery Patch Sales Volume by Company (2021-2026)
  4. 3.4 Global Microneedle-mediated Drug Delivery Patch Average Price by Company (2021-2026)
  5. 3.5 Global Microneedle-mediated Drug Delivery Patch Company Ranking (2024-2026)
  6. 3.6 Global Microneedle-mediated Drug Delivery Patch Company Manufacturing Base and Headquarters
  7. 3.7 Global Microneedle-mediated Drug Delivery Patch Company Product Type and Application
  8. 3.8 Global Microneedle-mediated Drug Delivery Patch Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Microneedle-mediated Drug Delivery Patch Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Microneedle-mediated Drug Delivery Patch Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Microneedle-mediated Drug Delivery Patch Market by Type
  1. 4.1 Microneedle-mediated Drug Delivery Patch Type Introduction
  2. 4.1.1 Solid Microneedle Technology
  3. 4.1.2 Hollow Microneedle Technology
  4. 4.1.3 Dissolving Microneedles Technology
  5. 4.2 Global Microneedle-mediated Drug Delivery Patch Sales Volume by Type
  6. 4.2.1 Global Microneedle-mediated Drug Delivery Patch Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Microneedle-mediated Drug Delivery Patch Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Microneedle-mediated Drug Delivery Patch Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Microneedle-mediated Drug Delivery Patch Sales Value by Type
  10. 4.3.1 Global Microneedle-mediated Drug Delivery Patch Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Microneedle-mediated Drug Delivery Patch Sales Value by Type (2021-2032)
  12. 4.3.3 Global Microneedle-mediated Drug Delivery Patch Sales Value Share by Type (2021-2032)
5 Microneedle-mediated Drug Delivery Patch Market by Application
  1. 5.1 Microneedle-mediated Drug Delivery Patch Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Retail Pharmacy
  4. 5.1.3 Others
  5. 5.2 Global Microneedle-mediated Drug Delivery Patch Sales Volume by Application
  6. 5.2.1 Global Microneedle-mediated Drug Delivery Patch Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Microneedle-mediated Drug Delivery Patch Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Microneedle-mediated Drug Delivery Patch Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Microneedle-mediated Drug Delivery Patch Sales Value by Application
  10. 5.3.1 Global Microneedle-mediated Drug Delivery Patch Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Microneedle-mediated Drug Delivery Patch Sales Value by Application (2021-2032)
  12. 5.3.3 Global Microneedle-mediated Drug Delivery Patch Sales Value Share by Application (2021-2032)
6 Microneedle-mediated Drug Delivery Patch Regional Sales and Value Analysis
  1. 6.1 Global Microneedle-mediated Drug Delivery Patch Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Microneedle-mediated Drug Delivery Patch Sales by Region (2021-2032)
  3. 6.2.1 Global Microneedle-mediated Drug Delivery Patch Sales by Region: 2021-2026
  4. 6.2.2 Global Microneedle-mediated Drug Delivery Patch Sales by Region (2027-2032)
  5. 6.3 Global Microneedle-mediated Drug Delivery Patch Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Microneedle-mediated Drug Delivery Patch Sales Value by Region (2021-2032)
  7. 6.4.1 Global Microneedle-mediated Drug Delivery Patch Sales Value by Region: 2021-2026
  8. 6.4.2 Global Microneedle-mediated Drug Delivery Patch Sales Value by Region (2027-2032)
  9. 6.5 Global Microneedle-mediated Drug Delivery Patch Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Microneedle-mediated Drug Delivery Patch Sales Value (2021-2032)
  12. 6.6.2 North America Microneedle-mediated Drug Delivery Patch Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Microneedle-mediated Drug Delivery Patch Sales Value (2021-2032)
  15. 6.7.2 Europe Microneedle-mediated Drug Delivery Patch Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Microneedle-mediated Drug Delivery Patch Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Microneedle-mediated Drug Delivery Patch Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Microneedle-mediated Drug Delivery Patch Sales Value (2021-2032)
  21. 6.9.2 South America Microneedle-mediated Drug Delivery Patch Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Microneedle-mediated Drug Delivery Patch Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Microneedle-mediated Drug Delivery Patch Sales Value Share by Country, 2025 VS 2032
7 Microneedle-mediated Drug Delivery Patch Country-level Sales and Value Analysis
  1. 7.1 Global Microneedle-mediated Drug Delivery Patch Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Microneedle-mediated Drug Delivery Patch Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Microneedle-mediated Drug Delivery Patch Sales by Country (2021-2032)
  4. 7.3.1 Global Microneedle-mediated Drug Delivery Patch Sales by Country (2021-2026)
  5. 7.3.2 Global Microneedle-mediated Drug Delivery Patch Sales by Country (2027-2032)
  6. 7.4 Global Microneedle-mediated Drug Delivery Patch Sales Value by Country (2021-2032)
  7. 7.4.1 Global Microneedle-mediated Drug Delivery Patch Sales Value by Country (2021-2026)
  8. 7.4.2 Global Microneedle-mediated Drug Delivery Patch Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Microneedle-mediated Drug Delivery Patch Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Microneedle-mediated Drug Delivery Patch Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Microneedle-mediated Drug Delivery Patch Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 KINDEVA
  2. 8.1.1 KINDEVA Company Information
  3. 8.1.2 KINDEVA Business Overview
  4. 8.1.3 KINDEVA Microneedle-mediated Drug Delivery Patch Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 KINDEVA Microneedle-mediated Drug Delivery Patch Product Portfolio
  6. 8.1.5 KINDEVA Recent Developments
  7. 8.2 Zosano Pharma
  8. 8.2.1 Zosano Pharma Company Information
  9. 8.2.2 Zosano Pharma Business Overview
  10. 8.2.3 Zosano Pharma Microneedle-mediated Drug Delivery Patch Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Zosano Pharma Microneedle-mediated Drug Delivery Patch Product Portfolio
  12. 8.2.5 Zosano Pharma Recent Developments
  13. 8.3 Vaxxas
  14. 8.3.1 Vaxxas Company Information
  15. 8.3.2 Vaxxas Business Overview
  16. 8.3.3 Vaxxas Microneedle-mediated Drug Delivery Patch Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Vaxxas Microneedle-mediated Drug Delivery Patch Product Portfolio
  18. 8.3.5 Vaxxas Recent Developments
  19. 8.4 Valeritas
  20. 8.4.1 Valeritas Company Information
  21. 8.4.2 Valeritas Business Overview
  22. 8.4.3 Valeritas Microneedle-mediated Drug Delivery Patch Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Valeritas Microneedle-mediated Drug Delivery Patch Product Portfolio
  24. 8.4.5 Valeritas Recent Developments
  25. 8.5 TheraJect, Inc
  26. 8.5.1 TheraJect, Inc Company Information
  27. 8.5.2 TheraJect, Inc Business Overview
  28. 8.5.3 TheraJect, Inc Microneedle-mediated Drug Delivery Patch Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 TheraJect, Inc Microneedle-mediated Drug Delivery Patch Product Portfolio
  30. 8.5.5 TheraJect, Inc Recent Developments
  31. 8.6 Nitto
  32. 8.6.1 Nitto Company Information
  33. 8.6.2 Nitto Business Overview
  34. 8.6.3 Nitto Microneedle-mediated Drug Delivery Patch Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Nitto Microneedle-mediated Drug Delivery Patch Product Portfolio
  36. 8.6.5 Nitto Recent Developments
  37. 8.7 Nanopass Technologies
  38. 8.7.1 Nanopass Technologies Company Information
  39. 8.7.2 Nanopass Technologies Business Overview
  40. 8.7.3 Nanopass Technologies Microneedle-mediated Drug Delivery Patch Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Nanopass Technologies Microneedle-mediated Drug Delivery Patch Product Portfolio
  42. 8.7.5 Nanopass Technologies Recent Developments
  43. 8.8 Microdermics
  44. 8.8.1 Microdermics Company Information
  45. 8.8.2 Microdermics Business Overview
  46. 8.8.3 Microdermics Microneedle-mediated Drug Delivery Patch Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Microdermics Microneedle-mediated Drug Delivery Patch Product Portfolio
  48. 8.8.5 Microdermics Recent Developments
  49. 8.9 Lohmann Therapie-Systeme AG
  50. 8.9.1 Lohmann Therapie-Systeme AG Company Information
  51. 8.9.2 Lohmann Therapie-Systeme AG Business Overview
  52. 8.9.3 Lohmann Therapie-Systeme AG Microneedle-mediated Drug Delivery Patch Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Lohmann Therapie-Systeme AG Microneedle-mediated Drug Delivery Patch Product Portfolio
  54. 8.9.5 Lohmann Therapie-Systeme AG Recent Developments
  55. 8.10 Corium
  56. 8.10.1 Corium Company Information
  57. 8.10.2 Corium Business Overview
  58. 8.10.3 Corium Microneedle-mediated Drug Delivery Patch Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Corium Microneedle-mediated Drug Delivery Patch Product Portfolio
  60. 8.10.5 Corium Recent Developments
  61. 8.11 Becton-Dickinson(BD)Technologies
  62. 8.11.1 Becton-Dickinson(BD)Technologies Company Information
  63. 8.11.2 Becton-Dickinson(BD)Technologies Business Overview
  64. 8.11.3 Becton-Dickinson(BD)Technologies Microneedle-mediated Drug Delivery Patch Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Becton-Dickinson(BD)Technologies Microneedle-mediated Drug Delivery Patch Product Portfolio
  66. 8.11.5 Becton-Dickinson(BD)Technologies Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Microneedle-mediated Drug Delivery Patch Value Chain Analysis
  2. 9.1.1 Microneedle-mediated Drug Delivery Patch Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Microneedle-mediated Drug Delivery Patch Sales Mode & Process
  6. 9.2 Microneedle-mediated Drug Delivery Patch Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Microneedle-mediated Drug Delivery Patch Distributors
  9. 9.2.3 Microneedle-mediated Drug Delivery Patch Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst